Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

715 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibitory actions of bilberry anthocyanidins on angiogenesis.
Matsunaga N, Tsuruma K, Shimazawa M, Yokota S, Hara H. Matsunaga N, et al. Phytother Res. 2010 Jan;24 Suppl 1:S42-7. doi: 10.1002/ptr.2895. Phytother Res. 2010. PMID: 19496063
Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.
Izuta H, Matsunaga N, Shimazawa M, Sugiyama T, Ikeda T, Hara H. Izuta H, et al. Among authors: matsunaga n. Mol Vis. 2010 Jan 29;16:130-6. Mol Vis. 2010. PMID: 20142849 Free PMC article.
Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo.
Matsunaga N, Imai S, Inokuchi Y, Shimazawa M, Yokota S, Araki Y, Hara H. Matsunaga N, et al. Mol Nutr Food Res. 2009 Jul;53(7):869-77. doi: 10.1002/mnfr.200800394. Mol Nutr Food Res. 2009. PMID: 19415665
Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo.
Matsunaga N, Chikaraishi Y, Shimazawa M, Yokota S, Hara H. Matsunaga N, et al. Evid Based Complement Alternat Med. 2010 Mar;7(1):47-56. doi: 10.1093/ecam/nem151. Epub 2007 Oct 27. Evid Based Complement Alternat Med. 2010. PMID: 18955266 Free PMC article.
Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H. Matsunaga N, et al. Ophthalmology. 2008 Nov;115(11):1916-22. doi: 10.1016/j.ophtha.2008.06.025. Epub 2008 Aug 21. Ophthalmology. 2008. PMID: 18718666
Rifampicin inhibits the retinal neovascularization in vitro and in vivo.
Chikaraishi Y, Matsunaga N, Shimazawa M, Hara H. Chikaraishi Y, et al. Among authors: matsunaga n. Exp Eye Res. 2008 Jan;86(1):131-7. doi: 10.1016/j.exer.2007.10.003. Epub 2007 Oct 14. Exp Eye Res. 2008. PMID: 18031740
Phosphatidylinositol inhibits vascular endothelial growth factor-A--induced migration of human umbilical vein endothelial cells.
Matsunaga N, Shimazawa M, Otsubo K, Hara H. Matsunaga N, et al. J Pharmacol Sci. 2008 Jan;106(1):128-35. doi: 10.1254/jphs.fp0071166. Epub 2008 Jan 11. J Pharmacol Sci. 2008. PMID: 18187933
A novel calpain inhibitor, ((1S)-1-((((1S)-1-Benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester (SNJ-1945), reduces murine retinal cell death in vitro and in vivo.
Shimazawa M, Suemori S, Inokuchi Y, Matsunaga N, Nakajima Y, Oka T, Yamamoto T, Hara H. Shimazawa M, et al. Among authors: matsunaga n. J Pharmacol Exp Ther. 2010 Feb;332(2):380-7. doi: 10.1124/jpet.109.156612. Epub 2009 Nov 12. J Pharmacol Exp Ther. 2010. PMID: 19910537
Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous.
Matsubara A, Ozeki H, Matsunaga N, Nozaki M, Ashikari M, Shirai S, Ogura Y. Matsubara A, et al. Among authors: matsunaga n. Br J Ophthalmol. 2001 Dec;85(12):1421-5. doi: 10.1136/bjo.85.12.1421. Br J Ophthalmol. 2001. PMID: 11734512 Free PMC article.
Ocular and systemic features of Peters' anomaly.
Ozeki H, Shirai S, Nozaki M, Sakurai E, Mizuno S, Ashikari M, Matsunaga N, Ogura Y. Ozeki H, et al. Among authors: matsunaga n. Graefes Arch Clin Exp Ophthalmol. 2000 Oct;238(10):833-9. doi: 10.1007/s004170000177. Graefes Arch Clin Exp Ophthalmol. 2000. PMID: 11127570
715 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback